Education
About Us
Working with TipRanks
Follow Us
Nirvana Life Sciences Inc (TSE:NIRV)
:NIRV
Total Valuation
Nirvana Life Sciences Inc has a market cap or net worth of C$1.60M. The enterprise value is C$440.68K.
Market CapC$1.60M
Enterprise ValueC$440.68K
Share Statistics
Nirvana Life Sciences Inc has 22,823,301 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,823,301
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nirvana Life Sciences Inc’s return on equity (ROE) is 0.25 and return on invested capital (ROIC) is 24.46%.
Return on Equity (ROE)0.25
Return on Assets (ROA)-18.81
Return on Invested Capital (ROIC)24.46%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Nirvana Life Sciences Inc is ―. Nirvana Life Sciences Inc’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio-0.34
Price to Fair Value-0.34
Price to FCF-7.29
Price to Operating Cash Flow-1.61
PEG Ratio0.00
Income Statement
In the last 12 months, Nirvana Life Sciences Inc had revenue of 0.00 and earned -365.92K in profits. Earnings per share was -0.08.
Revenue0.00
Gross Profit0.00
Operating Income-339.94K
Pretax Income-365.92K
Net Income-365.92K
EBITDA-321.63K
Earnings Per Share (EPS)-0.08
Cash Flow
In the last 12 months, operating cash flow was -994.85K and capital expenditures 0.00, giving a free cash flow of -994.85K billion.
Operating Cash Flow-994.85K
Free Cash Flow-994.85K
Free Cash Flow per Share-0.04
Dividends & Yields
Nirvana Life Sciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.52
52-Week Price Change-80.00%
50-Day Moving Average0.07
200-Day Moving Average0.08
Relative Strength Index (RSI)39.89
Average Volume (3m)184.00
Important Dates
Nirvana Life Sciences Inc upcoming earnings date is Apr 7, 2026, After Close (Not Confirmed).
Last Earnings DateDec 19, 2025
Next Earnings DateApr 7, 2026
Ex-Dividend Date―
Financial Position
Nirvana Life Sciences Inc as a current ratio of 0.01, with Debt / Equity ratio of -20.05%
Current Ratio0.01
Quick Ratio0.01
Debt to Market Cap0.19
Net Debt to EBITDA-0.30
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Nirvana Life Sciences Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Nirvana Life Sciences Inc EV to EBITDA ratio is -1.87, with an EV/FCF ratio of -8.67.
EV to Sales0.00
EV to EBITDA-1.87
EV to Free Cash Flow-8.67
EV to Operating Cash Flow-8.67
Balance Sheet
Nirvana Life Sciences Inc has C$1.74K in cash and marketable securities with C$104.79K in debt, giving a net cash position of -C$103.05K billion.
Cash & Marketable SecuritiesC$1.74K
Total DebtC$104.79K
Net Cash-C$103.05K
Net Cash Per Share>-C$0.01
Tangible Book Value Per Share-C$0.31
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Nirvana Life Sciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―